4.7 (438) In stock
Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturer
New NHS drug offers lifeline to 1,600 women with rare aggressive breast cancer
How the Covid-19 pandemic affected cancer screening services and what impact it has had on
NICE says new triple negative advanced breast cancer drug too expensive for NHS use, News, News
Breast cancer survival could be extended with two new drug combinations
Treatment for triple-negative breast cancer will now be available for patients in England
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer - The Institute of Cancer Research, London
Breast cancer: NHS England offers life-saving drug that can make tumour 'disappear
The rise of the 'long-waiter' – why cancer waiting times are showing the pressure more than ever before - Cancer Research UK - Cancer News
Kadcyla: Breast cancer drug breakthrough will see thousands women live longer and suffer no hair loss - Mirror Online
Action Cancer ambassador shares her journey after routine screening diagnosis
NHS England to roll out 'potentially life-saving' breast cancer drug
Life-saving' breast cancer drug to be offered on NHS